Cargando…
Complete remission in CD30-positive refractory extranodal NK/T-cell lymphoma with brentuximab vedotin
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4705052/ https://www.ncbi.nlm.nih.gov/pubmed/26770954 http://dx.doi.org/10.5045/br.2015.50.4.254 |
| _version_ | 1782408958354391040 |
|---|---|
| author | Kim, Hee Kyung Moon, Seong Mi Moon, Ji Hoon Park, Jee Eun Byeon, Seonggyu Kim, Won Seog |
| author_facet | Kim, Hee Kyung Moon, Seong Mi Moon, Ji Hoon Park, Jee Eun Byeon, Seonggyu Kim, Won Seog |
| author_sort | Kim, Hee Kyung |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4705052 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-47050522016-01-14 Complete remission in CD30-positive refractory extranodal NK/T-cell lymphoma with brentuximab vedotin Kim, Hee Kyung Moon, Seong Mi Moon, Ji Hoon Park, Jee Eun Byeon, Seonggyu Kim, Won Seog Blood Res Letter to the Editor Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2015-12 2015-12-21 /pmc/articles/PMC4705052/ /pubmed/26770954 http://dx.doi.org/10.5045/br.2015.50.4.254 Text en © 2015 Korean Society of Hematology http://creativecommons.org/licenses/by-nc/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letter to the Editor Kim, Hee Kyung Moon, Seong Mi Moon, Ji Hoon Park, Jee Eun Byeon, Seonggyu Kim, Won Seog Complete remission in CD30-positive refractory extranodal NK/T-cell lymphoma with brentuximab vedotin |
| title | Complete remission in CD30-positive refractory extranodal NK/T-cell lymphoma with brentuximab vedotin |
| title_full | Complete remission in CD30-positive refractory extranodal NK/T-cell lymphoma with brentuximab vedotin |
| title_fullStr | Complete remission in CD30-positive refractory extranodal NK/T-cell lymphoma with brentuximab vedotin |
| title_full_unstemmed | Complete remission in CD30-positive refractory extranodal NK/T-cell lymphoma with brentuximab vedotin |
| title_short | Complete remission in CD30-positive refractory extranodal NK/T-cell lymphoma with brentuximab vedotin |
| title_sort | complete remission in cd30-positive refractory extranodal nk/t-cell lymphoma with brentuximab vedotin |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4705052/ https://www.ncbi.nlm.nih.gov/pubmed/26770954 http://dx.doi.org/10.5045/br.2015.50.4.254 |
| work_keys_str_mv | AT kimheekyung completeremissionincd30positiverefractoryextranodalnktcelllymphomawithbrentuximabvedotin AT moonseongmi completeremissionincd30positiverefractoryextranodalnktcelllymphomawithbrentuximabvedotin AT moonjihoon completeremissionincd30positiverefractoryextranodalnktcelllymphomawithbrentuximabvedotin AT parkjeeeun completeremissionincd30positiverefractoryextranodalnktcelllymphomawithbrentuximabvedotin AT byeonseonggyu completeremissionincd30positiverefractoryextranodalnktcelllymphomawithbrentuximabvedotin AT kimwonseog completeremissionincd30positiverefractoryextranodalnktcelllymphomawithbrentuximabvedotin |